ASTRAZENECA GLUCOSE 10% w/v 1g/10mL injection BP ampoule অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

astrazeneca glucose 10% w/v 1g/10ml injection bp ampoule

phebra pty ltd - glucose, quantity: 100 mg/ml - injection, solution - excipient ingredients: sodium bicarbonate; water for injections - this product accepted for registration/listing as 'currently supplied' at the time of commencement of the act. indications held in artg paper records. (old code) indications as at 12 august 2003: glucose injection bp 10% is used in the treatment of carbohydrate and fluid depletion. glucose is the preferred source of carbohydrate in parenteral nutrition regimes, and is used in the treatment of dehydration due to acute diarrhoeal disease. glucose injection bp 10% is used in preference to the 5% solution to provide adequate calories in a minimal volume of water and glucose injection bp 10% may also be used to treat hypoglycaemia.

Glucose Injection (Baxter) নিউ জিলণ্ড - ইংরেজি - Medsafe (Medicines Safety Authority)

glucose injection (baxter)

baxter healthcare ltd - glucose monohydrate 10% - solution for infusion - 10 % - active: glucose monohydrate 10% - hypertonic infusion solutions are indicated: - as a source of energy incorporated with parenteral nutrition with minimal dilution effect - for use with an appropriate protein (nitrogen) source in the prevention of nitrogen loss or in the treatment of negative nitrogen balance in patients where: a) the alimentary tract cannot or should not be used b) gastrointestinal absorption of protein is impaired c) metabolic requirements for protein are substantially increased, as with extensive burns.

Glucose Injection (Baxter) নিউ জিলণ্ড - ইংরেজি - Medsafe (Medicines Safety Authority)

glucose injection (baxter)

baxter healthcare ltd - glucose monohydrate 25% - solution for infusion - 25 % - active: glucose monohydrate 25% - hypertonic infusion solutions are indicated: - as a source of energy incorporated with parenteral nutrition with minimal dilution effect - for use with an appropriate protein (nitrogen) source in the prevention of nitrogen loss or in the treatment of negative nitrogen balance in patients where: a) the alimentary tract cannot or should not be used b) gastrointestinal absorption of protein is impaired c) metabolic requirements for protein are substantially increased, as with extensive burns.

Glucose Injection (Baxter) নিউ জিলণ্ড - ইংরেজি - Medsafe (Medicines Safety Authority)

glucose injection (baxter)

baxter healthcare ltd - glucose monohydrate 50% - solution for infusion - 50 % - active: glucose monohydrate 50% - hypertonic infusion solutions are indicated: - as a source of energy incorporated with parenteral nutrition with minimal dilution effect - for use with an appropriate protein (nitrogen) source in the prevention of nitrogen loss or in the treatment of negative nitrogen balance in patients where: a) the alimentary tract cannot or should not be used b) gastrointestinal absorption of protein is impaired c) metabolic requirements for protein are substantially increased, as with extensive burns.

Glucose Injection (Baxter) নিউ জিলণ্ড - ইংরেজি - Medsafe (Medicines Safety Authority)

glucose injection (baxter)

baxter healthcare ltd - glucose monohydrate 70% - solution for infusion - 70 % - active: glucose monohydrate 70% - hypertonic infusion solutions are indicated: - as a source of energy incorporated with parenteral nutrition with minimal dilution effect - for use with an appropriate protein (nitrogen) source in the prevention of nitrogen loss or in the treatment of negative nitrogen balance in patients where: a) the alimentary tract cannot or should not be used b) gastrointestinal absorption of protein is impaired c) metabolic requirements for protein are substantially increased, as with extensive burns.

BAXTER 10% ANHYDROUS GLUCOSE 1000mL injection     AHB0164 অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

baxter 10% anhydrous glucose 1000ml injection ahb0164

baxter healthcare pty ltd - glucose, quantity: 100 g/l - injection, intravenous infusion - excipient ingredients: water for injections - this product accepted for registration/listing as 'currently supplied' at the time of commencement of the act. indications held in artg paper records. (old code)

BAXTER 5% GLUCOSE 100mL injection BP AHB0087 AHB0094 অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

baxter 5% glucose 100ml injection bp ahb0087 ahb0094

baxter healthcare pty ltd - glucose, quantity: 50 g/l - injection, solution - excipient ingredients: water for injections - this product accepted for registration/listing as 'currently supplied' at the time of commencement of the act. indications held in artg paper records. (old code)

BAXTER 5% GLUCOSE 50mL injection BP AHB0086 AHB0093 অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

baxter 5% glucose 50ml injection bp ahb0086 ahb0093

baxter healthcare pty ltd - glucose, quantity: 50 g/l - injection, solution - excipient ingredients: water for injections - this product accepted for registration/listing as 'currently supplied' at the time of commencement of the act. indications held in artg paper records. (old code)

BAXTER 10% ANHYDROUS GLUCOSE 500mL injection AHB0163 অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

baxter 10% anhydrous glucose 500ml injection ahb0163

baxter healthcare pty ltd - glucose, quantity: 100 g/l - injection, intravenous infusion - excipient ingredients: water for injections - this product accepted for registration/listing as 'currently supplied' at the time of commencement of the act. indications held in artg paper records. (old code)

GLUCOSE INJECTION BP 50% সিঙ্গাপুর - ইংরেজি - HSA (Health Sciences Authority)

glucose injection bp 50%

b. braun singapore pte ltd - glucose monohydrate - injection - 55 g/100 ml - glucose monohydrate 55 g/100 ml